Mobile

A Single Arm Phase II Study to assess the efficacy of intensified intravenous Melphalan in combination with a transplant of the patient's own blood stem cells for a maximum of three cycles in patients...

Update Il y a 4 ans
Reference: EUCTR2012-000351-14

A Single Arm Phase II Study to assess the efficacy of intensified intravenous Melphalan in combination with a transplant of the patient's own blood stem cells for a maximum of three cycles in patients with castration-resistant prostate cancer (CRPC)

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To determine the efficacy of intensified intravenous melphalan with autologous whole blood stem cell transplantation in patients with Castration-resistant prostate cancer using Progression Free Survival rate

Inclusion criteria

  • castration resistant prostate cancer patients

Links